Table 2.
Relationship between expression of PLOD2 and patient characteristics
Characteristics | Number | PLOD2 | P value | |
---|---|---|---|---|
| ||||
Low | High | |||
Total number | 50 | 23 | 27 | |
Age (years) | ||||
< 50 | 21 | 10 | 11 | NS |
≥ 50 | 29 | 13 | 16 | |
Tumor size (cm) | ||||
< 2 | 31 | 14 | 17 | NS |
≥ 2 | 19 | 9 | 10 | |
Tumor stage | ||||
I-II | 34 | 21 | 13 | 0.003 |
III-IV | 16 | 2 | 14 | |
ER status | ||||
Negative | 20 | 10 | 10 | NS |
Positive | 30 | 13 | 17 | |
PR status | ||||
Negative | 24 | 17 | 7 | 0.001 |
Positive | 26 | 6 | 20 | |
HER-2 status | ||||
Negative | 18 | 6 | 12 | NS |
Positive | 32 | 17 | 15 | |
Ki-67 status | ||||
Negative | 21 | 3 | 18 | < 0.001 |
Positive | 29 | 20 | 9 | |
Lymph nodal status | ||||
Negative | 30 | 20 | 10 | 0.001 |
Positive | 20 | 3 | 17 |
P values were calculated by χ2 test; NS represented not significant.